West Kazakhstan Medical Journal

Published date: Jun 02 2025

Journal Title: West Kazakhstan Medical Journal

Issue title: West Kazakhstan Medical Journal: Volume 67 Issue 2

Pages: 225 - 237

DOI: 10.18502/wkmj.v67i2.17708

Dinara Katashevakatashevad85@mail.ruMarat Ospanov West-Kazakhstan Medical University, Aktobe

Nurgul Alekenovaalekenova@zkmu.kzMarat Ospanov West-Kazakhstan Medical University, Aktobe

Nazgul Akhtayevaakhtaeva_nazgul@mail.ruAsfendiyarov Kazakh National Medical University, Almaty

Kamilla Faizullinalyazzat.k@mail.ruAsfendiyarov Kazakh National Medical University, Almaty

Eleonora Nurbaulinaeleonora_71@bk.ruMarat Ospanov West-Kazakhstan Medical University, Aktobe

Anuar D. Akhmetzhanlyazzat.k@mail.ruMarat Ospanov West-Kazakhstan Medical University, Aktobe

Antoniya YanakievaMedical University Sofia, Sofia

Introduction: Avoidable mortality, which can be categorized as preventable or treatable mortality, can be used to assess the performance of a healthcare system and identify priority interventions. The aim of this study is to examine mortality rates from cardiovascular disease (CVD) in Aktobe, Kazakhstan.

Materials and Methods: We extracted data from the National Research Center for Health Development in the Aktobe region by urban and rural areas. The calculations took into account the population’s age and mortality rates from chronic rheumatic heart disease (I05-I09), hypertension (I10-I15), ischemic heart disease (I20-I25), and cerebrovascular diseases (I60-I69) from 2019 to 2023, broken down by gender and 5-year age groups (0, 1–4, 5–9, to 71-74). Joinpoint regression is used to identify the average annual percentage change (AAPC).

Results: Avoidable mortality from CVD increased between 2019 and 2021, followed by a sharp decrease to 95.49 in 2022 and then to 96.19 per 100,000 people. Avoidable mortality was higher in rural areas and among males. Treatable mortality in the region was higher than preventable mortality. The leading causes of avoidable CVD were ischemic heart disease and cerebrovascular diseases. The AAPC of avoidable mortality from CVD in the Aktobe region was 2.1 (-29.7; 48.2), whereas treatable mortality was 2.4 (-29.0; 47.6), and preventable was 1.7 (-30.6; 48.9). The absolute change for avoidable mortality related to CVD was 16.96 per 100,000 people.

Conclusion: Our data indicate the need to strengthen work in hospitals and secondary prevention, as there is a high treatable mortality rate, especially in rural areas. Additionally, the high level of avoidable mortality rates among males indicates the need for a more in-depth analysis of the causes, particularly for ischemic heart disease and cerebrovascular diseases.

Keywords: avoidable mortality, primary health care, health policy, public health

[1] Cardiovascular diseases [internet]. World Health Organization; Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1

[2] Cherla A, Kyriopoulos I, Pearcy P, Tsangalidou Z, Hajrulahovic H, Theodorakis P, et al. Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995–2020: A retrospective secondary data analysis. Lancet Reg Health Eur. 2024;47:101079.

[3] Multiple cause of death data on CDC Wonder [Internet]. Centers for Disease Control and Prevention; [cited 2024 May 3]. Available from: https://wonder.cdc.gov/mcd.html

[4] Martin SS, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347–e913.

[5] Australian Bureau of Statistics. Causes of Death, Australia. Canberra: ABS; 2023. Available from: https://www.abs.gov.au/statistics/health/causes-death/causes-death-australia/latest-release

[6] Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya JC, et al. Cardiovascular, respiratory, and related disorders: Key messages from Disease Control Priorities, 3rd edition. Lancet. 2018;391(10126):1224–1236.

[7] Zhamantayev O, Smagulov N, Tykezhanova G, Kenzhekeyeva M, Karshalova G. Economic and healthcare influences on circulatory diseases in Kazakhstan: A retrospective ecological study. J Health Popul Nutr. 2024;43(1):196.

[8] Kodali PB. Achieving universal health coverage in low- and middle-income countries: Challenges for policy post-pandemic and beyond. Risk Manag Healthc Policy. 2023;16:607–621.

[9] Chan BT, Rauscher C, Issina AM, Kozhageldiyeva LH, Kuzembaeva DD, Davis CL, et al. A programme to improve quality of care for patients with chronic diseases, Kazakhstan. Bull World Health Organ. 2020;98(3):161–169.

[10] Об утверждении целевых групп лиц, подлежащих скрининговым исследованиям, а также правил, объема и периодичности проведения данных исследований [Internet]. 2020. Available from: https://adilet.zan.kz/rus/docs/V2000021572

[11] World Health Organization. WHO Primary Health Care Demonstration Platform. Copenhagen: WHO Regional Office for Europe; 2022.

[12] Rutstein DD, Berenberg W, Chalmers TC, Child CG 3rd, Fishman AP, Perrin EB. Measuring the quality of medical care. A clinical method. N Engl J Med. 1976;294(11):582–588.

[13] Nolte E, McKee M. Does Health care save lives? Avoidable mortality revisited. London: Nuffield Trust; 2004.

[14] Nolte E, McKee M. Variations in amenable mortality–Trends in 16 high-income nations. Health Policy. 2011;103(1):47–52.

[15] Canadian Institute for Health Information (CIHI). Health Indicators 2012. Ottawa, Ontario: CIHI; 2012.

[16] Australian Institute of Health and Welfare. Deaths in Australia [Internet]. Canberra: Australian Institute of Health and Welfare; 2025. Available from: https://www.aihw.gov.au/reports/life-expectancydeaths/ deaths-in-australia

[17] OECD. Health at a Glance 2019: OECD Indicators. Paris: OECD Publishing; 2019.

[18] Kosherbayeva L, Akhtayeva N, Tolganbayeva K, Samambayeva A. Trends in avoidable mortality in Kazakhstan from 2015 to 2021. Int J Health Policy Manag. 2024;13:7919.

[19] Department of Population Statistics. Life expectancy at birth of the population of the Republic of Kazakhstan for 2023. Astana: Department of Population Statistics; 2024.

[20] OECD. OECD health statistics: Definitions, sources and methods; 2023. https://www.oecd.org/content/ dam/oecd/en/data/datasets/oecd-health-statistics/214497-Table-of-Content-Metadata-OECDHealth- Statistics-2023.pdf/_jcr_content/renditions/original./214497-Table-of-Content-Metadata- OECD-Health-Statistics-2023.pdf

[21] Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: Joinpoint regression analysis. Popul Health Metr. 2017;15(1):23.

[22] Obermann K, Chanturidze T, Richardson E, Tanirbergenov S, Shoranov M, Nurgozhaev A. Data for development in health: A case study and monitoring framework from Kazakhstan. BMJ Glob Health. 2016;1(1):e000003.

[23] Centers for Disease Control and Prevention (CDC). Vital signs: Avoidable deaths from heart disease, stroke, and hypertensive disease - United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2013;62(35):721–727.

[24] Junusbekova G, Tundybayeva M, Akhtaeva N, Kosherbayeva L. Recent trends in cardiovascular disease mortality in Kazakhstan. Vasc Health Risk Manag. 2023;19:519–526.

[25] Oksuzyan A, Shkolnikova M, Vaupel JW, Christensen K, Shkolnikov VM. Sex differences in health and mortality in Moscow and Denmark. Eur J Epidemiol. 2014;29(4):243–252.

[26] Chung JI, Song YM, Choi JS, Kim BM. Trends in avoidable death over 20 years in Korea. J Korean Med Sci. 2008;23(6):975–981.

[27] Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA. Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet. 2018;392(10160):2203–2212.

[28] Reyes-Sánchez F, Basto-Abreu A, Torres-Alvarez R, Canto-Osorio F, González-Morales R, Dyer-Leal DD, et al. Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases. Prev Med. 2022;155:106917.

[29] Geng J, Yu X, Bao H, Feng Z, Yuan X, Zhang J, et al. Chronic diseases as a predictor for severity and mortality of COVID-19: A systematic review with cumulative meta-analysis. Front Med (Lausanne). 2021;8:588013.

[30] Woodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, et al. Trends in cardiovascular disease mortality rates and excess deaths, 2010–2022. Am J Prev Med. 2024;66(4):582–589.

[31] Mocumbi AO. Cardiovascular health care in low- and middle-income countries. Circulation. 2024;149(8):557–559.

[32] Hrzic R, Vogt T. The contribution of avoidable mortality to life expectancy differences and lifespan disparities in the European Union: A population-based study. Lancet Reg Health Eur. 2024;46:101042.

[33] Currie J, Schilling HT, Evans L, Boyce T, Lester N, Greene G, et al. Contribution of avoidable mortality to life expectancy inequalities in Wales: A decomposition by age and by cause between 2002 and 2020. J Public Health (Oxf). 2023;45(3):762–770.

[34] NORC Walsh Center for Rural Health Analysis. Exploring strategies to improve health and equity in rural communities. Bethesda; 2018.

[35] Morena A, Pulido J, Cea-Soriano L, Guerras JM, Ronda E, Lostao L. Rural-urban disparities in the reduction of avoidable mortality and mortality from all other causes of death in Spain, 2003–2019. J Public Health (Berl.). 2023.